AML, Childhood
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT05077423) | Y-mAbs Therapeutics | 2022-05-25 |
| AflacLL1901 (CHOA-AML) (NCT04326439) | Emory University | 2020-01-24 |
| Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML (NCT03825367) | Therapeutic Advances in Childhood Leukemia Consortium | 2019-11-29 |
Track AML, Childhood automatically
Every clearance here is in the API, with alerts when new ones post.